The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Annexin A1 and glucocorticoids as effectors of the resolution of inflammation
Abstract
Glucocorticoids are widely used for the management of inflammatory diseases. Their clinical application stems from our understanding of the inhibitory effect of the corticosteroid hormone cortisol on several components of the immune system. Endogenous and exogenous glucocorticoids mediate their multiple anti-inflammatory effects through many effector molecules. In this Opinion article, we focus on the role of one such effector molecule, annexin A1, and summarize the recent studies that provide insight into its molecular and pharmacological functions in immune responses. In addition, we propose a model in which glucocorticoids regulate the expression and function of annexin A1 in opposing ways in innate and adaptive immune cells to mediate the resolution of inflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By activating cell-surface receptors, pro-resolving mediators block inflammatory cell influx and promote the egress of inflammatory cells, modulate pro-inflammatory T cell responses and promote clearance of both pathogens and dead cells (efferocytosis), with all these functions serving to limit tissue damage and to enable the repair of injured tissue29,30.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [30]
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
Annexins: linking Ca2+ signalling to membrane dynamics
Gerke, V., Creutz, C. E., & Moss, S. E. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1661 · Cited by 1,412
Resolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045 · cited 1×
“The concept that inflammation is resolved in a time- and space-specific manner is emerging, such that different outcomes can be produced according to the stage or site at which a given pathway or mediator becomes operativ”
BackgroundSelf-citationPromotion of Tissue Inflammation by the Immune Receptor Tim-3 Expressed on Innate Immune Cells
Anderson, A. C., Anderson, D. E., Bregoli, L., Hastings, W. D., Kassam, N., Lei, C., Chandwaskar, R., Kármán, J., Su, E. W., Hirashima, M., et al. (2007) · Science · doi:10.1126/science.1148536 · Cited by 703
Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., & Adcock, I. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050466 · Cited by 638
Glucocorticoids and the Th1/Th2 Balance
Elenkov, I. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.010 · Cited by 618
Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro
Ramírez, F., Fowell, D. J., Puklavec, M. J., Simmonds, S. J., & Mason, D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2406 · Cited by 483
The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
Chiang, N., Serhan, C. N., Dahlén, S., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., & Brink, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.4 · Cited by 464
Cited by
Sorted by citations
Items 401–500 of 924
Kiapour, A. M., Sieker, J. T., Proffen, B. L., Lam, T. T., Fleming, B. C., & Murray, M. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212662 · Cited by 31
Mihaylova, N., Chipinski, P., Bradyanova, S. L., Velikova, T. V., Ivanova‐Todorova, E., Chausheva, S., Herbáth, M., Kalinova, D., Prechl, J., Kyurkchiev, D. S., et al. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13399 · Cited by 31
Chen, R., Chen, C., Han, N., Guo, W., Deng, H., Wang, Y., Ding, Y., & Zhang, M. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17458 · Cited by 31
Gobbetti, T., Ducheix, S., Faouder, P. L., Pérez, T., Riols, F., Boué, J., Bertrand‐Michel, J., Dubourdeau, M., Guillou, H., Perretti, M., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12957 · Cited by 31
Self-citationRecent Advances in Molecular and Cellular Functions of S100A10
Okura, G. C., Bharadwaj, A. G., & Waisman, D. M. (2023) · Biomolecules · doi:10.3390/biom13101450 · Cited by 30
Ampomah, P. B., Moraes, L. A., Lukman, H. M., & Lim, L. H. K. (2017) · The FASEB Journal · doi:10.1096/fj.201700584rr · Cited by 30
Comprehensive Atlas of the Myelin Basic Protein Interaction Landscape
Smirnova, E. V., Rakitina, T. V., Ziganshin, R., Arapidi, G. P., Saratov, G. A., Kudriaeva, A. A., & Belogurov, A. A. (2021) · Biomolecules · doi:10.3390/biom11111628 · Cited by 30
Zhao, Q., Wu, J., Lin, Z., Hua, Q., Zhang, W., Ye, L., Wu, G., Du, J., Xia, J. L., Chu, M., et al. (2016) · Inflammation · doi:10.1007/s10753-016-0364-9 · Cited by 32
Zhang, H., Lu, Y. W., Sun, G., Teng, F., Luo, N., Jiang, J., & Wen, A. (2017) · Critical Care · doi:10.1186/s13054-017-1757-3 · Cited by 30
Varga, G., Ehrchen, J. M., Brockhausen, A., Weinhage, T., Nippe, N., Belz, M., Tsianakas, A., Ross, M., Bettenworth, D., Spieker, T., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300891 · Cited by 29
The GR‐ANXA1 pathway is a pathological player and a candidate target in epilepsy
Zub, E., Canet, G., Garbelli, R., Blaquière, M., Rossini, L., Pastori, C., Sheikh, M. H., Reutelingsperger, C. P. M., Klément, W., de Bock, F., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901596r · Cited by 32
Reischl, S., Lee, J. H., Miltschitzky, E., Vieregge, V., Walter, R. L., Twardy, V., Kasajima, A., Frieß, H., Kamaly, N., & Neumann, P.-A. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab008 · Cited by 29
Ammendola, R., Parisi, M., Esposito, G., & Cattaneo, F. (2021) · Antioxidants · doi:10.3390/antiox10010134 · Cited by 29
Liotti, F., Marotta, M., Sorriento, D., Pagliuca, C., Caturano, V., Mantova, G., Scaglione, E., Salvatore, P., Melillo, R. M., & Prevete, N. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13280 · Cited by 30
Lee, S. H., Kim, D. W., Kim, H. R., Woo, S. J., Kim, S. M., Jo, H. S., Jeon, S. G., Cho, S., Park, J. H., Won, M. H., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.084 · Cited by 29
Horlacher, T., Noti, C., de Paz, J. L., Bindschädler, P., Hecht, M.-L., Smith, D. F., Fukuda, M., & Seeberger, P. H. (2011) · Biochemistry · doi:10.1021/bi101121a · Cited by 31
Machado, I. D., Spatti, M. C., Hastreiter, A. A., Santin, J. R., Fock, R. A., Gil, C. D., Oliani, S. M., Perretti, M., & Farsky, S. H. P. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25346 · Cited by 29
Self-citationZhou, G., Stevenson, M. M., Geary, T. G., & Xia, J. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004624 · Cited by 30
Annexin A1/Formyl Peptide Receptor Pathway Controls Uterine Receptivity to the Blastocyst
Hebeda, C. B., Sandri, S., Benis, C. M., de Paula-Silva, M., Loiola, R. A., Reutelingsperger, C. P. M., Perretti, M., & Farsky, S. H. P. (2020) · Cells · doi:10.3390/cells9051188 · Cited by 29
Self-citationAnnexin A1 in neurological disorders: Neuroprotection and glial modulation
Ferreira, L. P. D. S., da Silva, R. A., Borges, P. P., Xavier, L. F., Scharf, P. R. D. S., Sandri, S., Oliani, S. M., Farsky, S. H. P., & Gil, C. D. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108809 · Cited by 28
Mimetic peptide AC2-26 of annexin A1 as a potential therapeutic agent to treat COPD
Possebon, L., Costa, S. D. S., Souza, H. R., de Azevedo, L. R., Sant’Ana, M., Iyomasa-Pilon, M. M., Oliani, S. M., & Girol, A. P. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.08.011 · Cited by 28
Inflammatory and Pro-resolving Mediators in Frontotemporal Dementia and Alzheimer’s Disease
Fraga, V. G., Magalhaes, C. A., Loures, C. D. M. G., de Souza, L. C., Guimarães, H. C., Zauli, D. A. G., Ferriani, M. D. G. C., Ferreira, C. N., Caramelli, P., Sousa, L. P., et al. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.09.008 · Cited by 28
Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19
Sestili, P., & Stocchi, V. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00854 · Cited by 28
New Perspectives in the Study of Intestinal Inflammation: Focus on the Resolution of Inflammation
Camba-Gómez, M., Gualillo, O., & Conde, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052605 · Cited by 29
Lyngstadaas, A. V., Olsen, M. V., Bair, J. A., Hodges, R. R., Utheim, T. P., Serhan, C. N., & Dartt, D. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.618653 · Cited by 28
Raess, N., Schüetz, P., Cesana‐Nigro, N., Winzeler, B. F., Urwyler, S. A., Schaedelin, S. A., Rodondi, N., Blum, M. R., Briel, M., Müeller, B., et al. (2021) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1914 · Cited by 28
Mast cells modulate the inflammatory process in endotoxin-induced uveitis.
da Silva, P. S., Girol, A. P., & Oliani, S. M. (2011) · Europe PMC (PubMed Central) · Cited by 28
Expression of annexin A1 mRNA in peripheral blood from oral squamous cell carcinoma patients
de Faria, P. C. B., Sena, A. A. S., Nascimento, R., Carvalho, W. J., Loyola, A. M., da Silva, S. J., Durighetto, A. F., de Oliveira, A. R., Oliani, S. M., & Goulart, L. R. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2009.09.003 · Cited by 28
Molecular determinants of glucocorticoid actions in inflammatory joint diseases
Baschant, U., Culemann, S., & Tuckermann, J. P. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.009 · Cited by 29
Hayes, M. A., Quinn, B. A., Lillie, B. N., Bienzle, D., Waelchli, R., & BETTERIDGE, K. J. (2012) · Animal Reproduction · Cited by 28
Rüger, M., Kipp, E., Schubert, N., Schröder, N., Pufe, T., Stope, M. B., Kipp, M., Blume, C., Tauber, S. C., & Brandenburg, L. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02006-w · Cited by 28
Control of Myeloid Cell Trafficking in Resolution
Norling, L. V., & Perretti, M. (2013) · Journal of Innate Immunity · doi:10.1159/000350612 · Cited by 28
Self-citationAnnexin A1 Is Increased in the Plasma of Preeclamptic Women
Perucci, L. O., Carneiro, F. S., Ferreira, C. N., Sugimoto, M. A., Soriani, F. M., Martins, G. G., Lima, K. M., Guimarães, F. L., Teixeira, A. L., Dusse, L. M. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138475 · Cited by 27
Calpains Released by T Lymphocytes Cleave TLR2 To Control IL-17 Expression
Perez, J., Dansou, B., Hervé, R., Levi, C., Tamouza, H., Vandermeersch, S., Demey, E., Haymann, J., Zafrani, L., Klatzmann, D., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500749 · Cited by 29
Sinniah, A., Yazid, S., Perretti, M., Solito, E., & Flower, R. J. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.01.003 · Cited by 27
Self-citationProtein Markers Predict Survival in Glioma Patients
Stetson, L. C., Dazard, J.-E., & Barnholtz‐Sloan, J. S. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.060657 · Cited by 27
Chemical Characterization and Anti-Inflammatory Activity of Phytoconstituents from Swertia alata
Bajaj, S., Fuloria, S., Subramaniyan, V., Meenakshi, D. U., Wakode, S. R., Kaur, A. P., Bansal, H., Manchanda, S., Kumar, S., & Fuloria, N. K. (2021) · Plants · doi:10.3390/plants10061109 · Cited by 27
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence
Bruschi, M., Angeletti, A., Prunotto, M., Meroni, P. L., Ghiggeri, G. M., Moroni, G. L., Sinico, R. A., Franceschini, F., Fredi, M., Vaglio, A., et al. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103535 · Cited by 27
Rapp, C., Warta, R., Stamova, S., Nowrouzi, A., Geisenberger, C., Gal, Z., Roesch, S., Dettling, S., Juenger, S., Bucur, M., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1702-1 · Cited by 27
Role of neutrophils in equine asthma
Uberti, B., & Morán, G. (2018) · Animal Health Research Reviews · doi:10.1017/s146625231800004x · Cited by 28
Chen, Z., Yoshihara, E., Son, A., Matsuo, Y., Masutani, H., Sugie, K., Maeda, M., & Yodoi, J. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.04.003 · Cited by 27
Ning, J., Fan, X., Sun, K., Wang, X., Li, H., Jia, K., & Ma, C. (2023) · Inflammation · doi:10.1007/s10753-023-01803-8 · Cited by 26
López‐Muñoz, R., Molina‐Berríos, A., Campos‐Estrada, C., Abarca-Sanhueza, P., Urrutia-Llancaqueo, L., Peña-Espinoza, M., & Maya, J. D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01961 · Cited by 26
Jia, D. T., Zhang, C., Qiu, Y., Chen, X.-F., Jia, L., Chen, A. F., Chai, Y.-F., Zhu, Z., Huang, J., & Zhang, C. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0265-1 · Cited by 26
de Paula-Silva, M., da Rocha, G. H. O., Broering, M. F., Queiroz, M. L., Sandri, S., Loiola, R. A., Oliani, S. M., Vieira, A., Perretti, M., & Farsky, S. H. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714138 · Cited by 26
Self-citationAnnexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway
Li, P., Li, L., Li, Z., Wang, S., Li, R., Zhao, W., Feng, Y., Huang, S., Lü, L., Qiu, H., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-021-02427-4 · Cited by 26
Liotti, F., Marotta, M., Melillo, R. M., & Prevete, N. (2022) · Cancers · doi:10.3390/cancers14143333 · Cited by 27
Xu, R., Weber, M.-C., Hu, X., Neumann, P., & Kamaly, N. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101664 · Cited by 26
Félix, F. B., Dias, J., Vago, J. P., Martins, D. G., Beltrami, V. A., Fernandes, D. D. O., dos Santos, A. C. P. M., Queiroz‐Junior, C. M., Sousa, L. P., Amaral, F. A., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2022.106640 · Cited by 26
Annexins: Ca2+ Effectors Determining Membrane Trafficking in the Late Endocytic Compartment
Enrich, C., Rentero, C., Meneses‐Salas, E., Tebar, F., & Grewal, T. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55858-5_14 · Cited by 26
Lu, Q., Jin, Y., Mao, J. T., Zhang, Z., Heber, D., Dubinett, S. M., & Rao, J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.09.125 · Cited by 26
The role of annexins in central nervous system development and disease
White, Z. B., Nair, S., & Bredel, M. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02443-7 · Cited by 25
Liu, X., You, L.-H., Zhou, R., & Zhang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.14249 · Cited by 25
On the adaptive nature of Annexin-A1
D’Acquisto, F. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.04.007 · Cited by 25
Self-citationTrends in Analysis of Cortisol and Its Derivatives
Boolani, A., Channaveerappa, D., Dupree, E. J., Jayathirtha, M., Aslebagh, R., Grobe, S., Wilkinson, T., & Darie, C. C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-15950-4_39 · Cited by 24
Szczuko, M., Palma, J., Kikut, J., Komorniak, N., & Ziętek, M. (2020) · Inflammation Research · doi:10.1007/s00011-020-01358-6 · Cited by 24
Annexin A1 as a potential prognostic biomarker for COVID‐19 disease: Case–control study
Çanacık, Ö., Sabırlı, R., Altıntaş, E., Karslı, E., Karış, D., Kaymaz, B., Sabirli, G. T., Kurt, Ö., & Köseler, A. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14606 · Cited by 24
Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity
Spini, A., Giudice, V., Brancaleone, V., Morgese, M. G., Francia, S. D., Filippelli, A., Ruggieri, A., Ziche, M., Ortona, E., Cignarella, A., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105848 · Cited by 26
Maresin-1 and its receptors RORα/LGR6 as potential therapeutic target for respiratory diseases
Zhao, M., Li, C., Zhang, J., Yin, Z., Zheng, Z., Wan, J., & Wang, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106337 · Cited by 23
Mechanisms Limiting Renal Tissue Protection and Repair in Glomerulonephritis
Angeletti, A., Bruschi, M., Kajana, X., Spinelli, S., Verrina, E. E., Lugani, F., Caridi, G., Murtas, C., Candiano, G., Prunotto, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098318 · Cited by 24
The involvement of anti-inflammatory protein, annexin A1, in ocular toxoplasmosis.
Mimura, K. K. O., Tedesco, R. C., Calabrese, K. D. S., Gil, C. D., & Oliani, S. M. (2012) · Europe PMC (PubMed Central) · Cited by 24
New pathways to control inflammatory responses in adipose tissue
Akasheh, R. T., Pang, J., York, J. M., & Fantuzzi, G. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.04.008 · Cited by 25
Annexins in Influenza Virus Replication and Pathogenesis
Ampomah, P. B., Kong, W. T., Zharkova, O., Chua, S. C. J. H., Samy, R. P., & Lim, L. H. K. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01282 · Cited by 24
da Rocha, G. H. O., Loiola, R. A., Pantaleão, L. D. N., Reutelingsperger, C. P. M., Solito, E., & Farsky, S. H. P. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3433 · Cited by 24
The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease
Briottet, M., Shum, M., & Urbach, V. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01290 · Cited by 26
Peptides as Diagnostic, Therapeutic, and Theranostic Tools: Progress and Future Challenges
Thakur, R., Suri, C. R., Kaur, I. P., & Rishi, P. (2022) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2022040322 · Cited by 23
Annexins and cardiovascular diseases: Beyond membrane trafficking and repair
Méndez‐Barbero, N., Sebastián-Jaraba, I. S., Blázquez‐Serra, R., Martı́n-Ventura, J. L., & Blanco‐Colio, L. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1000760 · Cited by 23
Lack of TNFRI signaling enhances annexin A1 biological activity in intestinal inflammation
Sena, A. A. S., Pedrotti, L. P., Barrios, B. E., Cejas, H., Balderramo, D. C., Diller, A., & Correa, S. G. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.09.009 · Cited by 23
Liu, F., Pauluhn, J., Trübel, H., & Wang, C. (2013) · Toxicology · doi:10.1016/j.tox.2013.11.005 · Cited by 23
Regan-Komito, D., Valaris, S., Kapellos, T. S., Recio, C., Taylor, L., Greaves, D. R., & Iqbal, A. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01621 · Cited by 23
Annexin A1: A Bane or a Boon in Cancer? A Systematic Review
Ganesan, T., Sinniah, A., Ibrahim, Z. A., Chik, Z., & Alshawsh, M. A. (2020) · Molecules · doi:10.3390/molecules25163700 · Cited by 23
The Multifaceted Role of Annexin A1 in Viral Infections
Resende, F., de Araújo, S., Tavares, L. P., Teixeira, M. M., & Costa, V. V. (2023) · Cells · doi:10.3390/cells12081131 · Cited by 22
Narayan, M., Seeley, K. W., & Jinwal, U. K. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.09.024 · Cited by 22
Termination of Immune Activation: An Essential Component of Healthy Host Immune Responses
Kane, B. A., Bryant, K. J., McNeil, H. P., & Tedla, N. T. (2014) · Journal of Innate Immunity · doi:10.1159/000363449 · Cited by 22
Ledgard, A. M., Smolenski, G., Henderson, H. V., & Lee, R. S.-F. (2013) · Reproduction Fertility and Development · doi:10.1071/rd13144 · Cited by 22
Senthilkumaran, C., Clark, M. E., Abdelaziz, K., Bateman, K. G., MacKay, A., Hewson, J., & Caswell, J. (2013) · Veterinary Research · doi:10.1186/1297-9716-44-24 · Cited by 22
A Jack of All Trades: Impact of Glucocorticoids on Cellular Cross-Talk in Osteoimmunology
Ahmad, M., Hachemi, Y., Paxian, K., Mengele, F., Koenen, M., & Tuckermann, J. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02460 · Cited by 22
Alterations in the chondrocyte surfaceome in response to pro-inflammatory cytokines
Jeremiasse, B., Matta, C., Fellows, C. R., Boocock, D. J., Smith, J. R., Liddell, S., Lafeber, F. P. J. G., van Spil, W. E., & Mobasheri, A. (2020) · BMC Molecular and Cell Biology · doi:10.1186/s12860-020-00288-9 · Cited by 22
Santarsiero, A., Convertini, P., Vassallo, A., Santoro, V., Todisco, S., Iacobazzi, D., Fondufe‐Mittendorf, Y. N., Martelli, G., de Oliveira, M. R., Montanaro, R., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5533793 · Cited by 22
Puzzovio, P. G., Brüggemann, T. R., Pahima, H. T., Mankuta, D., Levy, B. D., & Levi‐Schaffer, F. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106172 · Cited by 22
Scientific Validation of Gentiana kurroo Royle for Anti-Inflammatory and Immunomodulatory Potential
Mubashir, K., Ghazanfar, K., Ganai, B. A., Akbar, S., Malik, A. H., & Masood, A. (2014) · ISRN Inflammation · doi:10.1155/2014/701765 · Cited by 21
Jelinic, M., Kahlberg, N., Leo, C. H., Ng, H. H., Rosli, S., Deo, M., Li, M., Finlayson, S. B., Walsh, J. L., Parry, L. J., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14927 · Cited by 21
Role of Annexin A1 Secreted by Neutrophils in Melanoma Metastasis
Sandri, S., Hebeda, C. B., Broering, M. F., Silva, M. D. P., Moredo, L. F., Silva, M. J. D. B. E., Molina, A. S., Pinto, C. A. L., Neto, J. P. D., Reutelingsperger, C. P. M., et al. (2023) · Cells · doi:10.3390/cells12030425 · Cited by 21
Desai, S., Nishad, S., Yadav, H. D., Shetake, N. G., Balla, M. M. S., Kumar, A., Ray, P., Ghosh, A., & Pandey, B. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161662 · Cited by 21
da Rocha, G. H. O., de Paula-Silva, M., Broering, M. F., Scharf, P. R. D. S., Matsuyama, L. S. A. S., Maria–Engler, S. S., & Farsky, S. H. P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.591561 · Cited by 21
Emerging contributions of formyl peptide receptors to neurodegenerative diseases
Busch, L., Vieten, S., Brödel, S., Endres, K., & Bufe, B. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0258 · Cited by 21
Halade, G. V., & Tourki, B. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21735-8_6 · Cited by 21
Abi‐Ghanem, C., Salinero, A. E., Kordit, D., Mansour, F. M., Kelly, R. D., Venkataganesh, H., Kyaw, N., Gannon, O. J., Riccio, D. A., Fredman, G., et al. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00513-y · Cited by 21
Qian, C., Xin, Y., Qi, C., Wang, H. M., Dong, B. C., Zack, D. J., Blackshaw, S., Hattar, S. S., Zhou, F., & Qian, J. X. (2024) · Nature Communications · doi:10.1038/s41467-024-46428-z · Cited by 20
Pathak, B. R., Breed, A. A., Apte, S., Acharya, K. K., & Mahale, S. D. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2564-2 · Cited by 20
Santin, J. R., Uchôa, F. D. T., de Lima, M. D. C. A., Rabello, M. M., Machado, I. D., Hernandes, M. Z., Amato, A. A., Milton, F. A., Webb, P., Neves, F. D. A. R., et al. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.029 · Cited by 20
Role of endogenous Annexin-A1 in the regulation of thymocyte positive and negative selection
Paschalidis, N., Huggins, A., Rowbotham, N. J., Furmanski, A. L., Crompton, T., Flower, R. J., Perretti, M., & D’Acquisto, F. (2010) · Cell Cycle · doi:10.4161/cc.9.4.10673 · Cited by 20
Self-citationKourkoulis, P., Michalopoulos, G., Katifelis, H., Giannopoulou, I., Lazaris, A. C., Papaconstantinou, I. G., Karamanolis, G. P., & Gazouli, M. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001783 · Cited by 20
ANXA1‑derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation
Feng, J., Xiao, T., Lu, S., Hung, X., Yi, H. L., He, Q., Huang, W., Tang, Y., & Xiao, Z. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5119 · Cited by 20
Wang, L.-M., Li, W., Xu, Y.-C., Wei, Q., Zhao, H., & Jiang, X. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000320228 · Cited by 20
Oliveira, L. G., Testasicca, M. C. D. S., Vago, J. P., Figueiredo, A. B., Canavaci, A. M. C., Perucci, L. O., Ferreira, T. P. T., Coelho, E. A. F., Gonçalves, D. U., Rocha, M. O. D. C., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602028 · Cited by 20
Morabito, G., Dönertaş, H. M., Sperti, L., Seidel, J., Zonouzi, A. P., Poeschla, M., & Valenzano, D. R. (2026) · Nature Aging · doi:10.1038/s43587-026-01086-2 · Cited by 19
Kim, Y. S., Oh, Y., Lee, H., Yang, B., Choi, C.-H., Jeong, H., Kim, H., & An, W.-G. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113843 · Cited by 19
Orbach, S. M., Brooks, M. D., Zhang, Y., Campit, S., Bushnell, G. G., Decker, J. T., Rebernick, R. J., Chandrasekaran, S., Wicha, M. S., Jeruss, J. S., et al. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-022-10185-4 · Cited by 19
Granulocyte development, tissue recruitment, and function during allergic inflammation
Radtke, D., & Voehringer, D. (2023) · European Journal of Immunology · doi:10.1002/eji.202249977 · Cited by 19
Metadata
- Authors
- Perretti, M., & D'Acquisto, F.
- Affiliations
- Queen Mary University of London (GB)
- Corresponding author
- Perretti, Mauro
- ORCID
- Perretti, Mauro
- Venue
- Nature Reviews Immunology
- Published
- 2009-01
- Volume
- 9
- Issue
- 1
- Pages
- 62-70
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2128864178
- Cited by
- 915
- References
- 84
- Citations by year
- 2026: 38 · 2025: 45 · 2024: 43 · 2023: 57 · 2022: 68 · 2021: 89 · 2020: 57 · 2019: 58 · 2018: 43 · 2017: 47 · 2016: 54 · 2015: 53 · 2014: 46 · 2013: 60 · 2012: 51
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- British Heart Foundation
- Versus Arthritis
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › S100 Proteins and Annexins
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- annexin A1, glucocorticoids, inflammation resolution, anti-inflammatory activity, cortisol, innate immune cells, adaptive immune cells
- MeSH terms
- Animals, Anti-Inflammatory Agents, Circadian Rhythm, Gene Expression Regulation, Glucocorticoids, Humans, Hydrocortisone, Immune System, Immunity, Innate, Inflammation, Macrophages, Monocytes, Neutrophils, T-Lymphocyte Subsets, Annexin A1, Mice, Knockout, Models, Immunological, Receptors, Formyl Peptide, Lipoxins, Receptors, Lipoxin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review